Ameritas Investment Partners’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.5K | Sell |
4,581
-1,451
| -24% | -$14.7K | ﹤0.01% | 2230 |
|
|
2025
Q1 | $33.7K | Hold |
6,032
| – | – | ﹤0.01% | 2320 |
|
|
2024
Q4 | $48.7K | Hold |
6,032
| – | – | ﹤0.01% | 2200 |
|
|
2024
Q3 | $61.8K | Hold |
6,032
| – | – | ﹤0.01% | 2069 |
|
|
2024
Q2 | $42.6K | Buy |
6,032
+2,809
| +87% | +$19.9K | ﹤0.01% | 2229 |
|
|
2024
Q1 | $44.3K | Hold |
3,223
| – | – | ﹤0.01% | 2220 |
|
|
2023
Q4 | $29.7K | Hold |
3,223
| – | – | ﹤0.01% | 2407 |
|
|
2023
Q3 | $19.5K | Hold |
3,223
| – | – | ﹤0.01% | 2549 |
|
|
2023
Q2 | $25K | Buy |
+3,223
| New | +$25K | ﹤0.01% | 2443 |
|
|
2022
Q2 | – | Sell |
-2,339
| Closed | -$12K | – | 3187 |
|
|
2022
Q1 | $12K | Hold |
2,339
| – | – | ﹤0.01% | 2741 |
|
|
2021
Q4 | $34K | Hold |
2,339
| – | – | ﹤0.01% | 2375 |
|
|
2021
Q3 | $49K | Buy |
2,339
+480
| +26% | +$10.1K | ﹤0.01% | 2167 |
|
|
2021
Q2 | $33K | Hold |
1,859
| – | – | ﹤0.01% | 2451 |
|
|
2021
Q1 | $46K | Hold |
1,859
| – | – | ﹤0.01% | 2132 |
|
|
2020
Q4 | $63K | Buy |
1,859
+1,090
| +142% | +$36.9K | ﹤0.01% | 1844 |
|
|
2020
Q3 | $19K | Hold |
769
| – | – | ﹤0.01% | 2408 |
|
|
2020
Q2 | $26K | Buy |
+769
| New | +$26K | ﹤0.01% | 2212 |
|